Provenance du réseau au premier degré de Kiyoshi Morita
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 30 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Kiyoshi Morita via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MITSUI & CO., LTD. | Chemicals: Major Diversified | Director/Board Member | |
| QUEST DIAGNOSTICS INCORPORATED | Services to the Health Industry | Corporate Officer/Principal | |
| SONY GROUP CORPORATION | Computer Processing Hardware | Director/Board Member | |
The Robert Wood Johnson Foundation
 The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous The Robert Wood Johnson Foundation (RWJF) is an independent philanthropic organization headquartered in Princeton, New Jersey. The firm was founded in 1972 and is dedicated solely to health. RWJF funds a wide array of programs which are working to help build a national Culture of Health. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Corporate Officer/Principal | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Medocity, Inc.
 Medocity, Inc. Medical/Nursing ServicesHealth Services Medocity, Inc. develops a care platform that bridges the gap between the clinic and the patient?s home. It offers a patient-centric mobile solution that combines key aspects of disease-specific care into a platform that can be used on application and Web-based devices. The firm platform also tracks key symptoms and side effects in real time; displays reports and graphic summaries to understand the patient?s health status on a daily basis. The company is headquartered in Parsippany, NJ. | Medical/Nursing Services | Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SUMITOMO MITSUI FINANCIAL GROUP, INC. | Major Banks | President | |
| AJINOMOTO CO., INC. | Food: Specialty/Candy | Director/Board Member | |
| NIKON CORPORATION | Electronics/Appliances | Director/Board Member | |
| MEI PHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Keio University | College/University | Corporate Officer/Principal | |
| Stony Brook University | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree | |
| University of Connecticut | College/University | Corporate Officer/Principal | |
| University of San Diego | College/University | Masters Business Admin | |
| University of Tokyo | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| QOL HOLDINGS CO., LTD. | Drugstore Chains | Director/Board Member | |
Keidanren
 Keidanren Miscellaneous Commercial ServicesCommercial Services Keidanren is a Japanese company based in Tokyo. The company's description is written in a mix of Japanese and English, making it difficult to understand. However, it appears that Keidanren is involved in various industries, including politics, economics, and culture. The non-profit company has a long history, dating back to 1946, and has been involved in promoting economic growth and development in Japan. | Miscellaneous Commercial Services | Director/Board Member | |
| Japan Association of Corporate Executives | Director/Board Member | ||
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Apo Plus Station Co., Ltd.
 Apo Plus Station Co., Ltd. Personnel ServicesCommercial Services Apo Plus Station Co., Ltd. provides employment placement services. It offers a series of services associated with sales of pharmaceuticals with sales and marketing operations. The firm also provides personal service which includes qualified medical personnel, recruitment websites set up for pharmacists and nurses and a website posting job offers from clinical trial firms is open to public. The company was founded on October 25, 1993 and is headquartered in Tokyo, Japan. | Personnel Services | Chief Executive Officer | |
| JAPAN POST HOLDINGS CO., LTD. | Life/Health Insurance | President Director/Board Member | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
| Tokyo Medical & Dental University | College/University | Doctorate Degree | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| Université Paris III Sorbonne Nouvelle | College/University | Doctorate Degree | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Compliance Officer | |
| CELCUITY INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Kitasato Daiichi Sankyo Vaccine Co., Ltd.
 Kitasato Daiichi Sankyo Vaccine Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Daiichi Sankyo Co., Ltd., Kitasato Daiichi Sankyo Vaccine Co., Ltd. develops, manufactures and distributes vaccines. The company is based in Kitamoto, Japan. Kitasato Daiichi Sankyo Vaccine Co. was acquired by Daiichi Sankyo Co., Ltd. from The Kitasato Institute on November 30, 2017. | Pharmaceuticals: Major | President President | |
Qol SD Holdings Co., Ltd.
 Qol SD Holdings Co., Ltd. Medical DistributorsDistribution Services Part of Qol Holdings Co., Ltd., Qol SD Holdings Co., Ltd. is a Japanese company that distributes pharmaceutical products. The company is based in Tokyo, Japan. | Medical Distributors | President | |
Taiho Oncology, Inc.
 Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Compliance Officer | |
| SOLID BIOSCIENCES INC. | Biotechnology | Director/Board Member | |
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Daiichi Sankyo Biotech Co. Ltd. | Chairman | ||
| TAYSHA GENE THERAPIES, INC. | Biotechnology | President | |
SalioGen Therapeutics, Inc.
 SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a clinical stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company has a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. Jaguar is rapidly advancing an initial pipeline of three programs, including targeting severe neurodevelopmental disorders, type 1 galactosemia, and type 1 diabetes. The company partner with Advanced Medicine Partners for manufacturing their therapeutics. Key investors include Deerfield Management Company, Arch Venture Partners, and Eli Lilly and Company. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| Rutgers Robert Wood Johnson Medical School | College/University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 27 |
| Japon | 19 |
| Suisse | 4 |
| France | 3 |
| Canada | 2 |
Sectorielle
| Health Technology | 23 |
| Consumer Services | 12 |
| Health Services | 4 |
| Finance | 4 |
| Commercial Services | 3 |
Opérationnelle
| Director/Board Member | 56 |
| Corporate Officer/Principal | 31 |
| Chief Tech/Sci/R&D Officer | 11 |
| President | 10 |
| Chairman | 10 |
Relations les plus connectées
| Insiders | |
|---|---|
| Sukumar Nagendran | 15 |
| Hiroshi Hirabayashi | 10 |
| Kunio Ishihara | 10 |
| Takashi Okimoto | 10 |
| Jay Feingold | 7 |
| Yoshifumi Nishikawa | 6 |
| Francis Plat | 6 |
| Susan Romanus | 6 |
| Joji Nakayama | 5 |
| Kazunori Hirokawa | 4 |
| Igor Gorbatchevsky | 4 |
| Ryuzo Takada | 4 |
| Takeshi Ogita | 3 |
| Toshiaki Tojo | 3 |
| Yuichiro Anzai | 3 |
- Bourse
- Insiders
- Kiyoshi Morita
- Connexions Sociétés
